AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Orphenadrine (Systemic).

USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language

| July 28, 2005 | COPYRIGHT 1996 USP DIĀ® and Advice for the PatientĀ® are registered trademarks of USP used under license to Micromedex, Inc. (Hide copyright information)Copyright
 
In the U.S. -- 
     Antiflex 
     Banflex 
     Flexoject 
     Mio-Rel 
     Myolin 
     Myotrol 
     Norflex 
     Orfro 
     Orphenate 
 
In Canada -- 
     Disipal 
     Norflex 
     Parkinsonism therapy adjunct 
 
      Skeletal muscle relaxant 
Description 

Orphenadrine ( or-FEN-a-dreen) is used to help relax certain muscles in your body and relieve the stiffness, pain, and discomfort caused by strains, sprains, or other injury to your muscles. One form of orphenadrine is also used to relieve trembling caused by Parkinson's disease. However, this medicine does not take the place of rest, exercise or physical therapy, or other treatment that your doctor may recommend for your medical problem.

Orphenadrine acts in the central nervous system (CNS) to produce its muscle relaxant effects. Orphenadrine also has other actions (anticholinergic) that produce its helpful effects in Parkinson's disease. Orphenadrine's CNS and anticholinergic actions may also be responsible for some of its side effects.

In the U.S., this medicine is available only with your doctor's prescription. In Canada, it may be available without a prescription. It is available in the following dosage forms:

 
Oral 
 
     Tablets (Canada) 
 
     Extended-release tablets (U.S. and Canada) 
Parenteral 
 
     Injection (U.S. and Canada) 
Before Using This Medicine 

In …

Related articles from newspapers, magazines, journals, and more
Orphenadrine (Systemic).(Drug overview)
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language August 1, 2006 700+ words
Orphenadrine (Systemic).
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language January 1, 1996 700+ words
Orphenadrine and aspirin (Systemic).
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language January 1, 1996 700+ words
Orphenadrine and Aspirin (Systemic).
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language October 27, 2005 700+ words
Orphenadrine and Aspirin (Systemic).(Drug overview)
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language August 1, 2006 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily